Association of Human Papillomavirus and p16 Status With Outcomes in the IMCL-9815 Phase III Registration Trial for Patients With Locoregionally Advanced Oropharyngeal Squamous Cell Carcinoma of the Head and Neck Treated With Radiotherapy With or Without Cetuximab [Rapid Communication]
Conclusion
p16 status was strongly prognostic for patients with OPC. The data suggest that the addition of cetuximab to RT improved clinical outcomes regardless of p16 or HPV status versus RT alone.
Source: Journal of Clinical Oncology - Category: Cancer & Oncology Authors: Rosenthal, Harari, Giralt, Bell, Raben, Liu, Schulten, Ang, Bonner Tags: Rapid Communications, Combined Modality, Rapid Communications Source Type: research
More News: Cancer & Oncology | Carcinoma | Erbitux | Genital Warts | HPV Testing | Human Papillomavirus (HPV) | Oropharyngeal Cancer | Skin Cancer | Squamous Cell Carcinoma | Study